Literature DB >> 11551768

Synthesis, biological activity and comparative analysis of DNA binding affinities and human DNA topoisomerase I inhibitory activities of novel 12-alkoxy-benzo[c]phenanthridinium salts.

M A Lynch1, O Duval, A Sukhanova, J Devy, S P MacKay, R D Waigh, I Nabiev.   

Abstract

New antitumor 12-alkoxy-benzo[c]phenanthridinium derivatives were obtained in high yields through multistep syntheses. Analysis of DNA binding and human DNA topoisomerase I inhibitory activities demonstrates that new compounds, combining 2, 6, and 12 substitutions, interact strongly with DNA and exhibit important topoisomerase I inhibition. The cytotoxicities against solid tumor cell lines are also determined and compared with those for fagaronine and ethoxidine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551768     DOI: 10.1016/s0960-894x(01)00520-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Synthesis of cyano-2,3-dihydropyrrolo[1,2-f]phenanthridine derivatives via a domino-Knoevenagel-cyclization.

Authors:  Ghasem Marandi; Malek T Maghsoodlou; Nourallah Hazeri; Sayyed M Habibi-Khorassani; Niloufar Akbarzadeh Torbati; Faramarz Rostami-Charati; Brian W Skelton; Mohamed Makha
Journal:  Mol Divers       Date:  2010-05-08       Impact factor: 2.943

2.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

3.  Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent.

Authors:  Farid Ouchani; Albin Jeanne; Jessica Thevenard; Jean-Jacques Helesbeux; Amandine Wahart; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier; Jérôme Devy
Journal:  Invest New Drugs       Date:  2014-11-19       Impact factor: 3.850

4.  Novel multicomponent reactions involving isoquinoline or phenanthridine and activated acetylenic ester in the presence of heterocyclic NH or 1,3-dicarbonyl compounds.

Authors:  Mahmoud Nassiri; Malek Taher Maghsoodlou; Reza Heydari; Sayyed Mostafa Habibi Khorassani
Journal:  Mol Divers       Date:  2008-07-18       Impact factor: 2.943

5.  Pro-Angiogenic Effects of Low Dose Ethoxidine in a Murine Model of Ischemic Hindlimb: Correlation between Ethoxidine Levels and Increased Activation of the Nitric Oxide Pathway.

Authors:  Nicolas Clere; Kim Hung Thien To; Samuel Legeay; Samuel Bertrand; Jean Jacques Helesbeux; Olivier Duval; Sébastien Faure
Journal:  Molecules       Date:  2017-04-12       Impact factor: 4.411

6.  Structurally Simple Phenanthridine Analogues Based on Nitidine and Their Antitumor Activities.

Authors:  Shu-Qin Qin; Lian-Chun Li; Jing-Ru Song; Hai-Yun Li; Dian-Peng Li
Journal:  Molecules       Date:  2019-01-26       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.